• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis.结核病与新冠肺炎严重程度及死亡率之间的关联：一项快速系统评价与荟萃分析
J Med Virol. 2021 Jan;93(1):194-196. doi: 10.1002/jmv.26311. Epub 2020 Jul 28.
2
Sex-based differences in severity and mortality in COVID-19.性别差异与 COVID-19 的严重程度和死亡率。
Rev Med Virol. 2021 Nov;31(6):e2223. doi: 10.1002/rmv.2223. Epub 2021 Mar 1.
3
SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.儿童中 SARS-CoV-2 RNAaemia：伊朗转诊医院的一项研究。
J Med Virol. 2021 Sep;93(9):5452-5457. doi: 10.1002/jmv.27065. Epub 2021 May 15.
4
An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality.关于结核病与新冠病毒疾病严重程度及死亡率之间关联的一项更新的荟萃分析。
J Med Virol. 2021 Oct;93(10):5682-5686. doi: 10.1002/jmv.27119. Epub 2021 Jun 9.
5
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.血脂异常与 2019 年冠状病毒病（COVID-19）严重程度和死亡率的关系：一项荟萃分析。
Virol J. 2021 Jul 27;18(1):157. doi: 10.1186/s12985-021-01604-1.
6
The relationship between severe or dead COVID-19 and asthma: A meta-analysis.重症或死亡型冠状病毒病与哮喘之间的关系：一项荟萃分析。
Clin Exp Allergy. 2021 Feb;51(2):354-359. doi: 10.1111/cea.13773. Epub 2020 Nov 12.
7
The association between serum prealbumin and poor outcome in COVID-19 - Systematic review and meta-analysis.血清前白蛋白与 COVID-19 不良预后的关系：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 May;25(10):3879-3885. doi: 10.26355/eurrev_202105_25955.
8
Asthma and atopy in COVID-19: 2021 updates.2019冠状病毒病中的哮喘与特应性：2021年更新内容
J Allergy Clin Immunol. 2022 Feb;149(2):562-564. doi: 10.1016/j.jaci.2021.12.762. Epub 2021 Dec 21.
9
IL-10 served as an indicator in severe COVID-19 patients.白细胞介素-10作为重症新型冠状病毒肺炎患者的一项指标。
J Med Virol. 2021 Mar;93(3):1233-1235. doi: 10.1002/jmv.26580. Epub 2020 Oct 30.
10
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.比较因 COVID-19、H7N9 和 H1N1 住院的患者。
Infect Dis Poverty. 2020 Dec 2;9(1):163. doi: 10.1186/s40249-020-00781-5.

引用本文的文献

1
Analysis of QuantiFERON-TB Gold Plus test results among patients with chronic inflammatory diseases and HIV patients.慢性炎症性疾病患者和HIV患者中QuantiFERON-TB Gold Plus检测结果分析。
North Clin Istanb. 2025 Jan 6;12(1):29-35. doi: 10.14744/nci.2023.88886. eCollection 2025.
2
Status and outlook of pulmonary tuberculosis coinfection.肺结核合并感染的现状与展望
J Res Med Sci. 2025 Jul 15;30:34. doi: 10.4103/jrms.jrms_446_23. eCollection 2025.
3
Causality between coronavirus disease 2019 and tuberculosis: A two-sample Mendelian randomization study.2019冠状病毒病与结核病之间的因果关系：一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Apr 25;104(17):e41999. doi: 10.1097/MD.0000000000041999.
4
Clinical outcomes of patients with coronavirus disease 2019 and active tuberculosis co-infection in Beijing China: A retrospective single-center descriptive study.中国北京2019冠状病毒病与活动性肺结核合并感染患者的临床结局：一项回顾性单中心描述性研究
Infect Med (Beijing). 2025 Feb 18;4(1):100169. doi: 10.1016/j.imj.2025.100169. eCollection 2025 Mar.
5
Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review.中医药治疗合并多系统疾病的新型冠状病毒肺炎的研究进展：一项范围综述
Infect Dis Poverty. 2024 Dec 19;13(1):97. doi: 10.1186/s40249-024-01263-8.
6
Exploring the shared pathogenic mechanisms of tuberculosis and COVID-19: emphasizing the role of VNN1 in severe COVID-19.探索结核病和新冠肺炎的共同致病机制：强调VNN1在重症新冠肺炎中的作用
Front Cell Infect Microbiol. 2024 Nov 21;14:1453466. doi: 10.3389/fcimb.2024.1453466. eCollection 2024.
7
Concurrent disease burden from multiple infectious diseases and the influence of social determinants in the contiguous United States.连续发生的多种传染病的疾病负担，以及连续美国的社会决定因素的影响。
PLoS One. 2024 Sep 4;19(9):e0293431. doi: 10.1371/journal.pone.0293431. eCollection 2024.
8
Sex disparities of the effect of the COVID-19 pandemic on mortality among patients living with tuberculosis in the United States.美国 COVID-19 大流行对结核病患者死亡率影响的性别差异。
Front Public Health. 2024 Jun 18;12:1413604. doi: 10.3389/fpubh.2024.1413604. eCollection 2024.
9
The clinical features and prognostic factors of miliary tuberculosis in a high tuberculosis burden area.高结核负担地区粟粒性结核的临床特征和预后因素。
Ann Med. 2024 Dec;56(1):2356647. doi: 10.1080/07853890.2024.2356647. Epub 2024 Jun 7.
10
A Descriptive Study on the Clinical Profile and Outcomes of Patients with COVID-19 and Tuberculosis Co-infection.新型冠状病毒肺炎与结核病合并感染患者的临床特征及预后的描述性研究
Acta Med Philipp. 2024 May 15;58(8):42-49. doi: 10.47895/amp.vi0.7855. eCollection 2024.

本文引用的文献

1
Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.饮酒与新冠病毒疾病严重程度无关：一项系统综述与荟萃分析
J Infect. 2020 Aug;81(2):e126-e127. doi: 10.1016/j.jinf.2020.05.042. Epub 2020 May 28.
2
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis.免疫抑制和免疫缺陷对新型冠状病毒肺炎的影响：一项系统综述和荟萃分析
J Infect. 2020 Aug;81(2):e93-e95. doi: 10.1016/j.jinf.2020.05.017. Epub 2020 May 15.
3
[Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province].[广东省新型冠状病毒肺炎病例临床结局及影响因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Dec 10;41(12):1999-2004. doi: 10.3760/cma.j.cn112338-20200318-00378.
4
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素：系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
5
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
6
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.中国武汉 COVID-19 老年患者的临床特征和结局：一项单中心回顾性研究。
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795. doi: 10.1093/gerona/glaa089.
7
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.预测 SARS-CoV-2 引起的 COVID-19 肺炎患者死亡率的前瞻性队列研究。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.00524-2020. Print 2020 May.
8
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.合并症会增加新冠肺炎患者的风险吗：来自荟萃分析的证据。
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057. doi: 10.18632/aging.103000.
9
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目：PRISMA声明。
BMJ. 2009 Jul 21;339:b2535. doi: 10.1136/bmj.b2535.

Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis.

作者信息

Gao Ya, Liu Ming, Chen Yamin, Shi Shuzhen, Geng Jie, Tian Jinhui

机构信息

Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, China.

出版信息

J Med Virol. 2021 Jan;93(1):194-196. doi: 10.1002/jmv.26311. Epub 2020 Jul 28.

DOI:10.1002/jmv.26311
PMID:32687228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7405273/
Abstract
摘要